Column Group Opportunity III, LP has an estimated net worth of $16.5 Million. This is based on reported shares across multiple companies, which include Eikon Therapeutics, Inc., Tenaya Therapeutics, Inc., Surrozen, Inc./DE, and NGM BIOPHARMACEUTICALS INC.

2025 was Column Group Opportunity III, LP's most active year for acquiring shares with 22 total transactions. Column Group Opportunity III, LP's most active month to acquire stocks was the month of December. 2026 was Column Group Opportunity III, LP's most active year for disposing of shares, totalling 19 transactions. Column Group Opportunity III, LP's most active month to dispose stocks was the month of January. 2026 saw Column Group Opportunity III, LP paying a total of $39,418,926.50 for 5,778,700 shares, this is the most they've acquired in one year. In 2026 Column Group Opportunity III, LP cashed out on 36,213,615 shares for a total of $5,927,198.65, their largest year based on trade value.